The expression of galectin-3 and galectin-9 on PC-3 cells that are proteins binding to β-galactoside sugars to provide potential biomarkers and therapeutic targets in particular cancer should be checked in the future [38,39]. This evidence concerns the gene LGALS3 and cancer.